Physician profile
Fielding Johnson
NPI 1346336237
$30,602.41
in general payments reported to CMS, 2019-2025
86 companies · $3,964 in 2025
The $3,964 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,347 · 2020: $3,283 · 2021: $4,505 · 2022: $4,229 · 2023: $4,149 · 2024: $5,126 · 2025: $3,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,978.62 |
| Education | $259.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,832.93 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $2,556.14 | 2019-2025 | Airsupra, Breztri, Bevespi Aerosphere |
| Amgen INC. | $1,997.57 | 2019-2025 | Repatha, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,637.68 | 2019-2025 | Jardiance, Ofev |
| Mallinckrodt Hospital Products INC. | $1,630.15 | 2020-2025 | Acthar |
| Abbvie INC. | $1,541.52 | 2021-2025 | |
| Abbott Laboratories | $1,347.41 | 2019-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $1,282.42 | 2019-2025 | Jardiance, Mounjaro, Lyumjev |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,221.07 | 2022-2025 | Caplyta |
| Sanofi-Aventis U.S. LLC | $791.09 | 2019-2024 | |
| Corcept Therapeutics | $668.99 | 2019-2025 | Korlym |
| Actelion Pharmaceuticals US, INC. | $610.38 | 2019-2025 | Opsumit, Uptravi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $588.88 | 2019-2025 | Xifaxan |
| Regeneron Healthcare Solutions, INC. | $557.17 | 2021-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $515.53 | 2019-2021 |
Show all 86 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $429.84 | 2019-2024 | Yupelri, Yupelri |
| Pfizer INC. | $398.50 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $392.07 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $379.62 | 2019-2024 | |
| Allergan, INC. | $361.17 | 2019-2020 | |
| Harmony Biosciences LLC | $320.28 | 2023-2025 | Wakix |
| Otsuka America Pharmaceutical, INC. | $311.10 | 2022-2025 | Rexulti |
| Novo Nordisk INC | $286.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $284.19 | 2023-2025 | Glassia |
| Neurocrine Biosciences, INC. | $280.48 | 2025 | |
| Amarin Pharma, INC. | $254.93 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $248.81 | 2019-2023 | Aveed |
| Lifescan, INC. | $243.84 | 2020-2022 | |
| Daiichi Sankyo INC. | $243.40 | 2019 | |
| Sunovion Pharmaceuticals INC. | $218.46 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $212.68 | 2020-2021 | |
| Grifols USA, LLC | $210.03 | 2019-2024 | Prolastin-C Liquid |
| Genzyme Corporation | $197.52 | 2021-2024 | |
| Alexion Pharmaceuticals, INC. | $180.81 | 2019-2024 | Strensiq |
| Pulmonx Corporation | $180.81 | 2024-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Phathom Pharmaceuticals, INC. | $158.74 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $148.23 | 2021-2022 | |
| Viatris Specialty LLC | $146.61 | 2025 | Yupelri |
| Cequr Corporation | $141.46 | 2023 | Cequr Simplicity |
| Exact Sciences Corporation | $140.40 | 2023-2025 | Cologuard Collection Kit |
| Antares Pharma, INC. | $140.01 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $138.71 | 2019-2021 | |
| Dexcom, INC. | $131.60 | 2021-2023 | Dexcom G6 Transmitter |
| Shire North American Group INC | $130.95 | 2019 | |
| Travere Therapeutics, INC. | $127.25 | 2025 | Filspari |
| Axsome Therapeutics, INC. | $127.15 | 2025 | Auvelity |
| Radius Health, INC. | $117.08 | 2019-2025 | Tymlos |
| Merck Sharp & Dohme LLC | $103.42 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $89.89 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Ultragenyx Pharmaceutical INC. | $73.35 | 2020-2024 | |
| Ibsa Pharma INC. | $72.84 | 2023-2024 | Tirosint, Licart, Tirosint |
| Amryt Pharma Holdings Ltd | $71.70 | 2023 | Mycapssa |
| Advanced Respiratory, INC | $63.60 | 2019 | |
| Verona Pharma, INC. | $63.06 | 2025 | Ohtuvayre |
| Alvogen INC | $58.51 | 2023-2025 | Teriparatide |
| Lundbeck LLC | $55.28 | 2024 | Rexulti |
| Mallinckrodt Enterprises LLC | $54.25 | 2019 | |
| Electromed, INC. | $53.53 | 2019-2023 | Smartvest |
| Kyowa Kirin, INC. | $52.32 | 2025 | |
| Eisai INC. | $47.97 | 2020-2021 | |
| Becton, Dickinson and Company | $47.06 | 2019-2021 | |
| Mannkind Corporation | $44.04 | 2025 | |
| Chiesi USA, INC. | $41.33 | 2024-2025 | Mycapssa |
| Inspire Medical Systems, INC. | $37.83 | 2024 | Inspire |
| Shield Therapeutics INC | $37.10 | 2023-2025 | Accrufer |
| Nabriva Therapeutics, Plc | $35.18 | 2021-2022 | |
| Ascensia Diabetes Care US INC. | $33.02 | 2019 | |
| Acerus Pharmaceuticals Corporation | $31.86 | 2020-2022 | |
| Insulet Corporation | $29.56 | 2019-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $29.05 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Recordati_rare_diseases_inc. | $28.01 | 2021-2023 | Signifor Lar, Isturisa |
| Circassia INC. | $27.97 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $27.53 | 2025 | Austedo Xr |
| Intra-Sana Laboratories | $24.37 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Philips North America LLC | $23.03 | 2021 | |
| Zealand Pharma US, INC. | $20.46 | 2021 | |
| Insmed, INC. | $20.41 | 2024 | Arikayce |
| Amphastar Pharmaceuticals, INC. | $19.68 | 2024 | Baqsimi |
| Gilead Sciences, INC. | $18.65 | 2021 | |
| Azurity Pharmaceuticals, INC. | $18.32 | 2025 | |
| Qiagen, LLC | $16.95 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.62 | 2025 | Nuzyra |
| Ipsen Biopharmaceuticals, INC | $15.35 | 2020 | |
| Medtronic, INC. | $14.13 | 2021 | |
| Progenics Pharmaceuticals, INC. | $12.08 | 2022 | |
| Shionogi INC | $12.03 | 2019 |
Drugs and devices associated with these payments
Caplyta $1,026Vraylar $1,006Freestyle Libre 3 $880Acthar $804Airsupra $796Nucala $748Trelegy Ellipta $604Dupixent $552Opsumit $376Yupelri $369Breztri $368Uptravi $351Repatha $328Wakix $320Evenity $309Jardiance $308Glassia $284Ingrezza $280Prolia $270Arexvy $257Xifaxan $217Rexulti $203Zephyr Delivery Catheter $181Chartis Catheter $181Pulmonx Chartis Tablet Console $181Zephyr Endobronchial Valve $181Voquezna $159Leqvio $142Cequr Simplicity $141Cologuard Collection Kit $140Ozempic $133Filspari $127Auvelity $127Synthroid $115Rybelsus $115Mycapssa $113Strensiq $108Tirosint $103Toujeo $85.96Mounjaro $85.75Licart $72.84Shingrix $70.60Ohtuvayre $63.06Prolastin-C Liquid $60.98Bevespi Aerosphere $60.86Otezla $58.72Teriparatide $58.51Qulipta $57.01Paxlovid $52.57Eliquis $52.57Crysvita $52.32Tymlos $52.21Dexcom G6 Transmitter $44.63Afrezza $44.04Korlym $43.70Recorlev $41.48Nurtec Odt $38.41Inspire $37.83Ubrelvy $37.69Accrufer $37.10Baqsimi $35.90Fasenra $35.41Soliqua 100/33 $34.92T:Slim X2 Insulin Pump With Control-Iq $29.05Austedo Xr $27.53Ofev $25.20Reltone 400 Mg $24.37Reltone 200 Mg $24.37Glycate $24.37Tepezza $23.82Wegovy $22.50Vyndamax $20.90Arikayce $20.41Gvoke Hypopen $19.82Symbicort $19.19Aveed $18.91Isturisa $18.72Signifor Lar $18.72Entresto $18.32Tzield $18.24Lyumjev $16.22Omnipod $15.70Nuzyra $15.62Nocdurna $15.29Xyosted $15.29Tlando $15.29Linzess $14.49Creon $14.49Comirnaty $14.16Smartvest $13.94
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fielding Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.